Similasan Eye Drops

Sep 02, 2023

Plowden v. Similasan Corp., Civil Action No. 1:23-cv-02511 (U.S. District Court for the District of Colorado).

This consumer class action alleges that Similasan Corp. is illegally marketing homeopathic products that claim to relieve various “minor eye symptoms” in contravention of the Federal Food, Drug, and Cosmetic Act and parallel state law. The complaint alleges that defendant is marketing a drug without having secured the appropriate approvals from the Federal Food and Drug Administration.

The complaint alleges that defendants have been cited by the FDA both for selling a drug without approval and for significant violations of Current Good Manufacturing Practices. The complaint further alleges that defendant’s eye drop products are considered adulterated by the FDA and should not be sold.

A copy of the complaint is available HERE.

If you have any questions concerning this case or would like to share your experience with Similasan’s products, please contact William Anderson, Esq. at 303-800-9109 or [email protected].

We are lawyers who seek to improve the world. We fight for: workers deprived of wages, consumers deceived about products, tenants denied access to housing, farmers mistreated by processors, parents deprived of adequate parental leave, investors who were defrauded, small businesses harmed by antitrust violations, persons with disabilities denied access, whistleblowers who uncover fraud, and women and communities of color subject to discrimination.

Get in touch


1201 Connecticut Avenue, NW
Suite 200K
Washington, DC 20036

ATTORNEY ADVERTISING. Prior results do not guarantee a similar outcome.